Jyothy Lab Inks JV with DRDO for Repellent
The Financial Express, February 14, 2011
Jyothy Laboratories today said it has tied
up with Defence Research and Development
Organisation (DRDO) to develop and market
an insect (mosquito) repellent.
The company said DRDO has recently developed
a new molecule -- Diethyl Phenyl Acetamide
(DEPA), which will be used for fighting
mosquitoes, which transmit diseases like
Malaria, Dengue and Chikungunia.
"DRDO has identified Jyothy Laboratories
to use DEPA technical to bring out multi-insect
repellent in its various formats to the
masses for their protection from painful
insect bites and vector borne diseases,"
Jyothy Laboratories said in a statement.
The company will market the product at
affordable prices to the masses, it added.
"We are honoured with the opportunity
provided to us by DRDO to help make these
products available at affordable prices
to the common man across the country,"
Jyothy Laboratories Chairman and Managing
M P Ramachandran said.
The company said extensive studies have
been conducted over the last two decades
ontoxicology, safety and bio-efficacy of
"Initiatives were taken under the
aegis of DRDO-FICCI-ATAC programme to make
available the benefits of DEPA to the common
man in India as well as in other countries,"
Jyothy Laboratories already sells household
insecticides under the brand "Maxo"....